Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa

The goal of the study is to investigate the safety, tolerability and efficacy of up to 3 doses of KIO-301 administered by intravitreal (IVT) injection bilaterally every 6 weeks in patients with late-stage retinitis pigmentosa (RP). Late-stage RP patients will include those patients with No Light Perception (NLP), or Low Vision (LV).

Participants needed: 36
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Kiora Pharmaceuticals, Inc.Updated: Jun 18, 2026Locations: 5
Eligibility criteria

Be aged 18 years or older at the time of consent. [+11]

Pregnant or breast-feeding, or plan to become pregnant during the study. [+14]

Read more
Status: Recruiting

Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema

This is a multi-center, open label study to assess the safety, tolerability, and efficacy of KIO-104 administered by IVT injection to the study eye of eligible participants with macular edema.

Participants needed: 28
Trial details
Phase: Phase 2Age: 18-85Biological sex: AllType: InterventionalSponsor: Kiora Pharmaceuticals, Inc.Updated: Jun 16, 2026Locations: 6
Eligibility criteria

Be aged 18 to 85 years inclusive at the time of consent. [+14]

Have media opacities (cornea, anterior or posterior synechia, cataract, vitreous... [+24]

Read more